These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7179188)

  • 1. Autologous x-irradiated tumour cells and percutaneous BCG in operable lung cancer.
    Stack BH; McSwan N; Stirling JM; Hole DJ; Spilg WG; McHattie I; Elliott JA; Gillis CR; Turner MA; White RG
    Thorax; 1982 Aug; 37(8):588-93. PubMed ID: 7179188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immunity in operable bronchial carcinoma: the effect of injecting irradiated autologous tumour cells and BCG.
    Stack BH; McSwan N; Stirling JM; Hole DJ; Parratt D; Spilg WG; Gillis CR; McHattie I; Green AG; White RG; Turner MA
    Thorax; 1979 Feb; 34(1):68-73. PubMed ID: 442002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of cancer patients with Bacillus Calmette-Guérin: summary of four years of experience in Japan.
    Torisu M; Fukawa M; Nishimura M; Harasaki H; Kai S; Tanaka J
    Ann N Y Acad Sci; 1976; 277(00):160-86. PubMed ID: 1069547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year results of a controlled study of BCG immunotherapy after surgical resection in bronchogenic carcinoma.
    Millar JW; Roscoe P; Pearce SJ; Ludgate S; Horne NW
    Thorax; 1982 Jan; 37(1):57-60. PubMed ID: 7041323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
    Jansen HM; The TH; Orie NG
    Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active specific immunotherapy with an autologous tumor cell vaccine in patients with resected non-small cell lung cancer.
    Schulof RS; Mai D; Nelson MA; Paxton HM; Cox JW; Turner ML; Mills M; Hix WR; Nochomovitz LE; Peters LC
    Mol Biother; 1988; 1(1):30-6. PubMed ID: 2855788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy with BCG in pulmonary tumors].
    Tanzj PL
    Minerva Med; 1976 Dec; 67(63):4167-72. PubMed ID: 1018810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG immunotherapy of lung cancer.
    Holmes EC
    Jpn J Surg; 1980 Mar; 10(1):1-6. PubMed ID: 7373947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.
    Vermorken JB; Claessen AM; van Tinteren H; Gall HE; Ezinga R; Meijer S; Scheper RJ; Meijer CJ; Bloemena E; Ransom JH; Hanna MG; Pinedo HM
    Lancet; 1999 Jan; 353(9150):345-50. PubMed ID: 9950438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
    McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological responsiveness and adjunct immunotherapy in lung cancer.
    Fukushima M; Machida S; Kakuta H; Nishikawa T; Kikuchi A; Takashima K; Ishioka T; Ishikawa Y
    Jpn J Surg; 1978 Dec; 8(4):300-7. PubMed ID: 732053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantoux, DNCB test, peripheral blood phagocyte activity and serum immunoglobulin levels in BCG vaccination treatment of lung tumor patients.
    Prugberger E; Hegyi P; Drinóczy M
    Dev Biol Stand; 1986; 58 ( Pt A)():395-9. PubMed ID: 3596045
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
    McCulloch PB; Dent PB; Blajchman M; Muirhead WM; Price RA
    Can Med Assoc J; 1977 Jul; 117(1):33-6. PubMed ID: 861909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283.
    Harris JE; Ryan L; Hoover HC; Stuart RK; Oken MM; Benson AB; Mansour E; Haller DG; Manola J; Hanna MG
    J Clin Oncol; 2000 Jan; 18(1):148-57. PubMed ID: 10623705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
    Kokoschka EM; Cerni C; Micksche M
    Oncology; 1977; 34(5):229-33. PubMed ID: 917456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.
    Bakker W; Nijhuis-Heddes JM; Wever AM; Brutel de la Rivière A; van der Velde EA; Dijkman JH
    Thorax; 1981 Nov; 36(11):870-4. PubMed ID: 7330812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy.
    Little AG; DeMeester TR; Ferguson MK; Skinner DB; Hoffman PC; Skosey C; Blough RR; Golomb HM
    Surgery; 1986 Oct; 100(4):621-8. PubMed ID: 3020725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BCG vaccine immunotherapy after radical operations for lung cancer].
    Repin IuM
    Vestn Khir Im I I Grek; 1992; 149(7-8):11-6. PubMed ID: 1341347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.
    Bakker W; Nijhuis-Heddes JM; van der Velde EA
    Cancer Immunol Immunother; 1986; 22(2):155-9. PubMed ID: 3719595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.